Frontlight ResearchEarly access
Trial site
Hopital Claude Huriez - CHU de Lille
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Gastric and oesophageal cancer1 trial
- Lung cancer1 trial
- Pancreatic cancer1 trial
- Thyroid cancer1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 24 trials
- Phase 34 trials
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Not yet recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- Eli Lilly and Company3 trials
- Fondation Franc.Cancerologie Digestive3 trials
- French Innovative Leukemia Organization1 trial
- Hospices Civils de Lyon1 trial
- Loxo Oncology, Inc.1 trial
Running trials
Recruiting
Recruiting
Not yet recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Active, not recruiting
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
Site data: ClinicalTrials.govUpdated 17 Nov 2026